Hirschsprung disease and hepatoblastoma
case report of a rare association
Keywords:
Hirschsprung disease, Hepatoblastoma, Intestinal atresia, Hearing loss, sensorineural, CataractAbstract
CONTEXT: Hirschsprung disease is a developmental disorder of the enteric nervous system that is characterized by absence of ganglion cells in the distal intestine, and it occurs in approximately 1 in every 500,000 live births. Hepatoblastoma is a malignant liver neoplasm that usually occurs in children aged 6 months to 3 years, with a prevalence of 0.54 cases per 100,000. CASE REPORT: A boy diagnosed with intestinal atresia in the first week of life progressed to a diagnosis of comorbid Hirschsprung disease. Congenital cataracts and sensorineural deafness were diagnosed. A liver mass developed and was subsequently confirmed to be a hepatoblastoma, which was treated by means of surgical resection of 70% of the liver volume and neoadjuvant chemotherapy (ifosfamide, cisplatin and doxorubicin). CONCLUSION: It is known that Hirschsprung disease may be associated with syndromes predisposing towards cancer, and that hepatoblastoma may also be associated with certain congenital syndromes. However, co-occurrence of hepatoblastoma and Hirschsprung disease has not been previously described. We have reported a case of a male patient born with ileal atresia, Hirschsprung disease and bilateral congenital cataract who was later diagnosed with hepatoblastoma.
Downloads
References
Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg. 2008;17(4):266-75.
Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1-14.
Finegold MJ, Egler RA, Goss JA et al. Liver tumors: pediatric population. Liver Transpl. 2008;14(11):1545-56.
Orphant Report Series. Rare Diseases collection. Prevalence of rare diseases: bibliographic data. Listed in alphabetical order of disease or group diseases. 2014;1. Available from: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. Accessed in 2014 (Dec 2).
Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013;25(3):368-74.
Butler Tjaden NE, Trainor PA. The development etiology and pathogenesis of Hirschsprung disease. Transl Res. 2013;162(1):1-15.
Weinberg AG, Currarino G, Besserman AM. Hirschsprung’s disease and congenital deafness. Familial association. Hum Genet. 1977;38(2):157-61.
Skinner R, Irvine D. Hirschsprung’s disease and congenital deafness. J Med Genet. 1973;10(4):337-9.
Litten JB, Tomlinson GE. Liver tumors in children. Oncologist. 2008;13(7):812-20.
Honeyman JN, La Quaglia MP. Malignant liver tumors. Semin Pediatr Surg. 2012;21(3):245-54.
Surveillance, Epidemiology, and End Results Program. Previous Version: SEER Cancer Statistics Review, 1975-2010. Available from: http://seer.cancer.gov/csr/1975_2010/sections.html. Accessed in 2014 (Dec 2).
Bulterys M, Goodman MT, Smith MA, Buckley JD. Hepatic tumors. In: Ries LA, Smith MA, Gurney JG, et al., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program, 1999. NIH Pub. No. 99-4649. p. 91-8. Available from: http://seer.cancer.gov/archive/publications/childhood/childhood-monograph.pdf. Accessed in 2014 (Dec 2).
Ikeda H, Hachitanda Y, Tanimura M, et al. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review. Cancer. 1998;82(9):1789-96.
de Camargo B, de Oliveira Ferreira JM, de Souza Reis R, et al. Socioeconomic status and the incidence of non-central nervous system childhood embryonic tumours in Brazil. BMC Cancer. 2011;11:160.
de Camargo B, de Oliveira Santos M, Rebelo MS, et al. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer. 2010;126(3):715-20.
Tanimura M, Matsui I, Abe J, et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res. 1998;58(14):3032-5.
Schnater JM, Köhler SE, Lamers WH, et al. Where do we stand with hepatoblastoma? A review. Cancer. 2003;98(4):668-78.
